 |
At the Special Clinic, I see patients with cutaneous
adverse drug reactions from the University Hospital
and referred cases that are difficult to diagnose and
treat. For severe cases, follow-up care after the severe
symptoms abate is particularly important. Final identification
of the causative drugs and long-term
monitoring of DIHS are done at the clinic.
In fiscal 2013, I treated one case of toxic epidermal
necrolysis (TEN), five cases of Stevens-Johnson syndrome
(SJS) and five cases of DIHS (including a
suspected case). The accumulation of data on severe
cases of cutaneous adverse drug reactions has progressed,
and I was able to publish papers in which I
used that information (e.g., J Allergy Clin Immunol
2013, Clin Immunol 2013). I’m grateful to the referring
doctors. If you have any drug eruption cases—or suspected
cases—that are hard to diagnose or treat,
please feel free to refer them to the clinic.
|  |